How Much Weight People Lost on Zepbound, Wegovy and Foundayo
Average weight loss from the main trials for tirzepatide, semaglutide and orforglipron — and the one number that matters more than the averages.
4 articles in Medications.
Average weight loss from the main trials for tirzepatide, semaglutide and orforglipron — and the one number that matters more than the averages.
These medications don't flood your brain — they reach a few specific places that sit outside its security barrier. Understanding which ones explains both why appetite quiets down and why nausea is the signature side effect.
Medicare's GLP-1 Bridge gives eligible Part D members Wegovy, Zepbound, or Foundayo for a flat $50 a month. Here's who qualifies, how to actually get it, and the four mistakes sending people home empty-handed.
Menstrual changes are one of the most-discussed GLP-1 side effects online — and one of the least documented. Here's what a 410,000-post analysis found, plus the contraception warning many people never hear.